Logo image of KSI.CA

KNEAT.COM INC (KSI.CA) Stock Fundamental Analysis

TSX:KSI - Toronto Stock Exchange - CA4988241010 - Common Stock - Currency: CAD

6.47  -0.17 (-2.56%)

Fundamental Rating

4

Taking everything into account, KSI scores 4 out of 10 in our fundamental rating. KSI was compared to 6 industry peers in the Health Care Technology industry. KSI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. KSI is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year KSI has reported negative net income.
In the past year KSI had a positive cash flow from operations.
KSI had negative earnings in each of the past 5 years.
In multiple years KSI reported negative operating cash flow during the last 5 years.
KSI.CA Yearly Net Income VS EBIT VS OCF VS FCFKSI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

With a decent Return On Assets value of -6.20%, KSI is doing good in the industry, outperforming 66.67% of the companies in the same industry.
With an excellent Return On Equity value of -11.87%, KSI belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
Industry RankSector Rank
ROA -6.2%
ROE -11.87%
ROIC N/A
ROA(3y)-15.47%
ROA(5y)-16.49%
ROE(3y)-45.71%
ROE(5y)-39.12%
ROIC(3y)N/A
ROIC(5y)N/A
KSI.CA Yearly ROA, ROE, ROICKSI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

KSI has a Gross Margin of 75.11%. This is in the better half of the industry: KSI outperforms 66.67% of its industry peers.
KSI's Gross Margin has improved in the last couple of years.
KSI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.7%
GM growth 5Y11.01%
KSI.CA Yearly Profit, Operating, Gross MarginsKSI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

6

2. Health

2.1 Basic Checks

KSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
KSI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, KSI has more shares outstanding
KSI has a better debt/assets ratio than last year.
KSI.CA Yearly Shares OutstandingKSI.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
KSI.CA Yearly Total Debt VS Total AssetsKSI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

KSI has an Altman-Z score of 5.90. This indicates that KSI is financially healthy and has little risk of bankruptcy at the moment.
KSI has a Altman-Z score of 5.90. This is amongst the best in the industry. KSI outperforms 100.00% of its industry peers.
KSI has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
KSI's Debt to Equity ratio of 0.38 is amongst the best of the industry. KSI outperforms 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 5.9
ROIC/WACCN/A
WACC7.26%
KSI.CA Yearly LT Debt VS Equity VS FCFKSI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

KSI has a Current Ratio of 2.28. This indicates that KSI is financially healthy and has no problem in meeting its short term obligations.
KSI has a Current ratio of 2.28. This is in the better half of the industry: KSI outperforms 66.67% of its industry peers.
A Quick Ratio of 2.28 indicates that KSI has no problem at all paying its short term obligations.
The Quick ratio of KSI (2.28) is better than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.28
Quick Ratio 2.28
KSI.CA Yearly Current Assets VS Current LiabilitesKSI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 50.41% over the past year.
Looking at the last year, KSI shows a very strong growth in Revenue. The Revenue has grown by 43.00%.
Measured over the past years, KSI shows a very strong growth in Revenue. The Revenue has been growing by 65.43% on average per year.
EPS 1Y (TTM)50.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.65%
Revenue 1Y (TTM)43%
Revenue growth 3Y46.7%
Revenue growth 5Y65.43%
Sales Q2Q%39.94%

3.2 Future

KSI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.97% yearly.
The Revenue is expected to grow by 34.94% on average over the next years. This is a very strong growth
EPS Next Y6.38%
EPS Next 2Y48.75%
EPS Next 3Y46.97%
EPS Next 5YN/A
Revenue Next Year38.17%
Revenue Next 2Y36.04%
Revenue Next 3Y33.84%
Revenue Next 5Y34.94%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
KSI.CA Yearly Revenue VS EstimatesKSI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
KSI.CA Yearly EPS VS EstimatesKSI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.05 -0.05 0.1 -0.1 -0.15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KSI. In the last year negative earnings were reported.
Also next year KSI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KSI.CA Price Earnings VS Forward Price EarningsKSI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100

4.2 Price Multiples

66.67% of the companies in the same industry are more expensive than KSI, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 138.09
KSI.CA Per share dataKSI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

A more expensive valuation may be justified as KSI's earnings are expected to grow with 46.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.75%
EPS Next 3Y46.97%

More info and screens

0

5. Dividend

5.1 Amount

KSI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KNEAT.COM INC

TSX:KSI (3/7/2025, 7:00:00 PM)

6.47

-0.17 (-2.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)05-06 2025-05-06
Inst Owners14.24%
Inst Owner ChangeN/A
Ins Owners8.66%
Ins Owner ChangeN/A
Market Cap607.92M
Analysts80
Price Target8.01 (23.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.38%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)2.47%
Revenue beat(4)2
Avg Revenue beat(4)0.42%
Min Revenue beat(4)-1.71%
Max Revenue beat(4)2.47%
Revenue beat(8)4
Avg Revenue beat(8)-0.11%
Revenue beat(12)7
Avg Revenue beat(12)1.61%
Revenue beat(16)11
Avg Revenue beat(16)5.04%
PT rev (1m)28.69%
PT rev (3m)33.62%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.57%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.71%
Revenue NY rev (3m)-0.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.42
P/FCF N/A
P/OCF 62.1
P/B 9.34
P/tB 21.12
EV/EBITDA 138.09
EPS(TTM)-0.09
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)0.1
OCFY1.61%
SpS0.52
BVpS0.69
TBVpS0.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.2%
ROE -11.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.11%
FCFM N/A
ROA(3y)-15.47%
ROA(5y)-16.49%
ROE(3y)-45.71%
ROE(5y)-39.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.7%
GM growth 5Y11.01%
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 5.9
Cap/Depr 196.17%
Cap/Sales 40.63%
Interest Coverage N/A
Cash Conversion 233.79%
Profit Quality N/A
Current Ratio 2.28
Quick Ratio 2.28
Altman-Z 5.9
F-Score6
WACC7.26%
ROIC/WACCN/A
Cap/Depr(3y)219.46%
Cap/Depr(5y)224.77%
Cap/Sales(3y)49.12%
Cap/Sales(5y)62.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.65%
EPS Next Y6.38%
EPS Next 2Y48.75%
EPS Next 3Y46.97%
EPS Next 5YN/A
Revenue 1Y (TTM)43%
Revenue growth 3Y46.7%
Revenue growth 5Y65.43%
Sales Q2Q%39.94%
Revenue Next Year38.17%
Revenue Next 2Y36.04%
Revenue Next 3Y33.84%
Revenue Next 5Y34.94%
EBIT growth 1Y56.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year248.87%
EBIT Next 3Y64.07%
EBIT Next 5Y48.98%
FCF growth 1Y45.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3054.19%
OCF growth 3Y61.83%
OCF growth 5YN/A